Literature DB >> 31497905

Th17 cell pathogenicity and plasticity in rheumatoid arthritis.

Pei Yang1, Fei-Ya Qian1, Ming-Fei Zhang1, A-Lan Xu1, Xiang Wang1, Bao-Ping Jiang1, Ling-Ling Zhou1.   

Abstract

CD4+ Th cells play an important role in the development of rheumatoid arthritis (RA) by regulating adaptive immune response. As major subsets of CD4+ Th cells, Th17 cells can produce a large number of hallmark cytokines such as IL-17A and IL-17F, which participate in host defense and immune homeostasis. However, increasing researches have shown that Th17 cells are unstable and exhibit a certain degree of plasticity, which aggravates their pathogenicity. Furthermore, the plasticity and pathogenicity of Th17 cells are closely related with the disease activity in RA. In this paper, the characteristics including phenotype, differentiation, plasticity, and pathogenicity of Th17 cells in RA will be systematically summarized. This will contribute to clarify the immunologic mechanism of RA and further provide a novel strategy for the clinical treatment of autoimmune diseases. ©2019 Society for Leukocyte Biology.

Entities:  

Keywords:  Th17 cells; pathogenicity; plasticity; rheumatoid arthritis

Mesh:

Substances:

Year:  2019        PMID: 31497905     DOI: 10.1002/JLB.4RU0619-197R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  33 in total

1.  miR-126-5p regulates H9c2 cell proliferation and apoptosis under hypoxic conditions by targeting IL-17A.

Authors:  Yin Ren; Ruanzhong Bao; Zhujun Guo; Jin Kai; Chen-Ge Cai; Zhu Li
Journal:  Exp Ther Med       Date:  2020-11-23       Impact factor: 2.447

Review 2.  Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.

Authors:  Alessandro Maglione; Miriam Zuccalà; Martina Tosi; Marinella Clerico; Simona Rolla
Journal:  Genes (Basel)       Date:  2021-07-29       Impact factor: 4.096

Review 3.  Th17.1 lymphocytes: emerging players in the orchestra of immune-mediated inflammatory diseases.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Clin Rheumatol       Date:  2022-05-11       Impact factor: 3.650

4.  Morin, the PPARγ agonist, inhibits Th17 differentiation by limiting fatty acid synthesis in collagen-induced arthritis.

Authors:  Yumeng Miao; Xiaoqian Wu; Xinru Xue; Xingyu Ma; Ling Yang; Xi Zeng; Yuxiao Hu; Yue Dai; Zhifeng Wei
Journal:  Cell Biol Toxicol       Date:  2022-09-19       Impact factor: 6.819

5.  Silence of S1PR4 Represses the Activation of Fibroblast-like Synoviocytes by Regulating IL-17/STAT3 Signaling Pathway.

Authors:  Pengyu Zhang; Qiang Zhang; Zhenxia Shao
Journal:  Inflammation       Date:  2022-09-06       Impact factor: 4.657

Review 6.  The non-coding RNA interactome in joint health and disease.

Authors:  Shabana A Ali; Mandy J Peffers; Michelle J Ormseth; Igor Jurisica; Mohit Kapoor
Journal:  Nat Rev Rheumatol       Date:  2021-09-29       Impact factor: 20.543

Review 7.  Calcium Signaling in T Cells and Chronic Inflammatory Disorders of the Oral Cavity.

Authors:  S Hasiakos; Y Gwack; M Kang; I Nishimura
Journal:  J Dent Res       Date:  2021-02-04       Impact factor: 8.924

8.  Emergent dynamics of a three-node regulatory network explain phenotypic switching and heterogeneity: a case study of Th1/Th2/Th17 cell differentiation.

Authors:  Atchuta Srinivas Duddu; Sauma Suvra Majumdar; Sarthak Sahoo; Siddharth Jhunjhunwala; Mohit Kumar Jolly
Journal:  Mol Biol Cell       Date:  2022-03-30       Impact factor: 3.612

9.  Punicalagin ameliorates collagen-induced arthritis by downregulating M1 macrophage and pyroptosis via NF-κB signaling pathway.

Authors:  Gaoran Ge; Jiaxiang Bai; Qing Wang; Xiaolong Liang; Huaqiang Tao; Hao Chen; Minggang Wei; Junjie Niu; Huilin Yang; Yaozeng Xu; Yuefeng Hao; Yi Xue; Dechun Geng
Journal:  Sci China Life Sci       Date:  2021-06-10       Impact factor: 6.038

Review 10.  Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases.

Authors:  Qi Jiang; Guocan Yang; Fan Xiao; Jue Xie; Shengjun Wang; Liwei Lu; Dawei Cui
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.